Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

The expression of HCV-associated host factors is dependent on the hepatoma cell line used in HCV studies.

Hoffmann TW, Delfosse F, Helle F, François C, Duverlie G, Castelain S.

Arch Virol. 2014 Mar;159(3):527-34. doi: 10.1007/s00705-013-1862-9. Epub 2013 Oct 8.

PMID:
24100473
2.

Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines.

Takeda M, Ikeda M, Ariumi Y, Wakita T, Kato N.

J Gen Virol. 2012 Jul;93(Pt 7):1422-31. doi: 10.1099/vir.0.040725-0. Epub 2012 Mar 28.

PMID:
22456614
3.

Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.

Helle F, Brochot E, Fournier C, Descamps V, Izquierdo L, Hoffmann TW, Morel V, Herpe YE, Bengrine A, Belouzard S, Wychowski C, Dubuisson J, Francois C, Regimbeau JM, Castelain S, Duverlie G.

PLoS One. 2013 Aug 5;8(8):e70809. doi: 10.1371/journal.pone.0070809. Print 2013.

4.

Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells.

Frentzen A, Anggakusuma, Gürlevik E, Hueging K, Knocke S, Ginkel C, Brown RJ, Heim M, Dill MT, Kröger A, Kalinke U, Kaderali L, Kuehnel F, Pietschmann T.

Hepatology. 2014 Jan;59(1):78-88. doi: 10.1002/hep.26626. Epub 2013 Nov 18.

PMID:
23873628
5.

Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA.

Sejima H, Mori K, Ariumi Y, Ikeda M, Kato N.

Virus Res. 2012 Jul;167(1):74-85. doi: 10.1016/j.virusres.2012.04.008. Epub 2012 May 1.

PMID:
22579597
6.

Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.

Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, Crawford JM, Nelson DR, Liu C.

Gastroenterology. 2007 Nov;133(5):1649-59. Epub 2007 Sep 16.

PMID:
17983809
7.

Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.

Nandakumar R, Finsterbusch K, Lipps C, Neumann B, Grashoff M, Nair S, Hochnadel I, Lienenklaus S, Wappler I, Steinmann E, Hauser H, Pietschmann T, Kröger A.

Gastroenterology. 2013 Dec;145(6):1414-23.e1. doi: 10.1053/j.gastro.2013.08.037. Epub 2013 Aug 21.

PMID:
23973921
8.

MicroRNA-130a inhibits HCV replication by restoring the innate immune response.

Li S, Duan X, Li Y, Liu B, McGilvray I, Chen L.

J Viral Hepat. 2014 Feb;21(2):121-8. doi: 10.1111/jvh.12131. Epub 2013 Jul 30.

PMID:
24383925
9.

Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.

Moschen AR, Fritz T, Clouston AD, Rebhan I, Bauhofer O, Barrie HD, Powell EE, Kim SH, Dinarello CA, Bartenschlager R, Jonsson JR, Tilg H.

Hepatology. 2011 Jun;53(6):1819-29. doi: 10.1002/hep.24285. Epub 2011 May 14.

PMID:
21381070
10.

High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1.

Cheng M, Si Y, Niu Y, Liu X, Li X, Zhao J, Jin Q, Yang W.

J Virol. 2013 Sep;87(17):9707-18. doi: 10.1128/JVI.00802-13. Epub 2013 Jul 3.

11.

MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes.

Banaudha K, Kaliszewski M, Korolnek T, Florea L, Yeung ML, Jeang KT, Kumar A.

Hepatology. 2011 Jan;53(1):53-61. doi: 10.1002/hep.24016. Epub 2010 Oct 21.

PMID:
20967756
12.

DNA methyltransferases 1 and 3B are required for hepatitis C virus infection in cell culture.

Chen C, Pan D, Deng AM, Huang F, Sun BL, Yang RG.

Virology. 2013 Jun 20;441(1):57-65. doi: 10.1016/j.virol.2013.03.005. Epub 2013 Mar 29.

13.

Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.

Eyre NS, Phillips RJ, Bowden S, Yip E, Dewar B, Locarnini SA, Beard MR.

J Hepatol. 2009 Sep;51(3):446-57. doi: 10.1016/j.jhep.2009.04.025. Epub 2009 Jun 3.

PMID:
19596477
14.

Mutual antagonism between circadian protein period 2 and hepatitis C virus replication in hepatocytes.

Benegiamo G, Mazzoccoli G, Cappello F, Rappa F, Scibetta N, Oben J, Greco A, Williams R, Andriulli A, Vinciguerra M, Pazienza V.

PLoS One. 2013 Apr 8;8(4):e60527. doi: 10.1371/journal.pone.0060527. Print 2013.

15.

Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus.

Fukuhara T, Kambara H, Shiokawa M, Ono C, Katoh H, Morita E, Okuzaki D, Maehara Y, Koike K, Matsuura Y.

J Virol. 2012 Aug;86(15):7918-33. doi: 10.1128/JVI.00567-12. Epub 2012 May 16.

16.

Primary hepatocyte culture supports hepatitis C virus replication: a model for infection-associated hepatocarcinogenesis.

Banaudha K, Orenstein JM, Korolnek T, St Laurent GC 3rd, Wakita T, Kumar A.

Hepatology. 2010 Jun;51(6):1922-32. doi: 10.1002/hep.23616. Erratum in: Hepatology. 2011 Feb;53(2):720.

PMID:
20512986
17.

Human immunodeficiency virus enhances hepatitis C virus replication by differential regulation of IFN and TGF family genes.

Zhang X, Daucher M, Baeza J, Kim CW, Russell R, Kottilil S.

J Med Virol. 2012 Sep;84(9):1344-52. doi: 10.1002/jmv.23315.

PMID:
22825812
18.

In vitro infection of immortalized primary hepatocytes by HCV genotype 4a and inhibition of virus replication by cyclosporin.

El-Farrash MA, Aly HH, Watashi K, Hijikata M, Egawa H, Shimotohno K.

Microbiol Immunol. 2007;51(1):127-33.

19.

Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication.

von Hahn T, Schiene-Fischer C, Van ND, Pfaender S, Karavul B, Steinmann E, Potthoff A, Strassburg C, Hamdi N, Abdelaziz AI, Sarrazin C, Müller T, Berg T, Trépo E, Wedemeyer H, Manns MP, Pietschmann T, Ciesek S.

Gastroenterology. 2012 Aug;143(2):439-47.e1. doi: 10.1053/j.gastro.2012.04.053. Epub 2012 May 8.

PMID:
22580540
20.

Microarray analysis identifies a common set of cellular genes modulated by different HCV replicon clones.

Ciccaglione AR, Marcantonio C, Tritarelli E, Tataseo P, Ferraris A, Bruni R, Dallapiccola B, Gerosolimo G, Costantino A, Rapicetta M.

BMC Genomics. 2008 Jun 30;9:309. doi: 10.1186/1471-2164-9-309.

Supplemental Content

Support Center